Keros Therapeutics, Inc.

KROS ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
8-K Sep 29, 2026 8-K
8-K Sep 28, 2026 8-K
EFFECT Sep 16, 2026
DEL AM Sep 11, 2026 DEL AM
S-3 Sep 10, 2026 S-3
8-K Sep 8, 2026 8-K
4 Aug 20, 2026
4 Aug 20, 2026
4 Aug 20, 2026
4 Aug 20, 2026
4 Aug 19, 2026
144 Aug 18, 2026
3 Aug 13, 2026
8-K Aug 3, 2026 8-K
10-Q Aug 3, 2026 10-Q
8-K Aug 3, 2026 8-K
8-K Jul 30, 2026 8-K
SCHEDULE 13G/A Jul 29, 2026
8-K Jul 22, 2026 8-K
4 Jul 17, 2026
SCHEDULE 13G Jul 17, 2026
4 Jul 6, 2026
3 Jul 6, 2026
8-K Jun 25, 2026 8-K
4 Jun 17, 2026
← Newer Page 1 of 22 · 532 filings Older →